Pharmacy
Novartis oral multiple sclerosis development compound Gilenia granted US priority review status
The FINANCIAL -- Gilenia (FTY720, fingolimod) has been granted priority review status by the US Food and Drug Administration (FDA),...
Novartis receives FDA approval for meningitis vaccine
The FINANCIAL -- Novartis AG (NVS: News ) announced that Menveo, a quadrivalent meningococcal conjugate vaccine was approved by the...
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents
The FINANCIAL -- Daiichi Sankyo, Inc. announced on February 15 that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment...
My child matters Supports Seven New Childhood Cancer Care Projects
The FINANCIAL -- On February 15, on the International Childhood Cancer Day, the International Union Against Cancer (UICC) and sanofi-aventis...
Daiichi Sankyo: new influenza drug may boost flagging Japanese market
The FINANCIAL -- Daiichi Sankyo Company, Limited (hereafter; Daiichi Sankyo), announced on February 8 that its subsidiary, ASUBIO PHARMA CO., LTD. (Head...
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
The FINANCIAL -- Cephalon, Inc. (Nasdaq: CEPH) announced on February 1 that it has signed an agreement to acquire Mepha AG...
Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958
The FINANCIAL -- Daiichi Sankyo Company, Limited (hereafter; Daiichi Sankyo), on February 1 announced that it has submitted a New Drug Application...
First Treatment to Improve Survival in 20 Years Now Available for Patients with Osteosarcoma
The FINANCIAL -- Takeda Pharmaceutical Company Limited (“Takeda”) and Takeda Pharmaceuticals Europe Limited (“TPEU”), its wholly owned subsidiary for oversight...
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial
The FINANCIAL -- Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (STO: BVT) on January 25 announced that the first patient was...
Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII
The FINANCIAL -- Bayer Schering Pharma AG, Germany has announced that an independent Data Safety and Monitoring Board (DSMB) has...
Novartis launches schizophrenia treatment Fanapt in the US
The FINANCIAL -- Novartis announced that Fanapt(TM) (iloperidone) tablets are now available for use across the US for the acute...
Sanofi-Aventis to Buy Chattem
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Chattem, Inc. (NASDAQ: CHTT) announced on December 21 that they...
KRKA – winner of 2009 PORTAL prize for exemplary IR and CG – for the third consecutive year
The FINANCIAL -- The Ljubljana Stock Exchange has awarded its 14th annual Portal prize, which compliments exemplary investors relations and corporate...
UCB reveals results of trial into safety of certolizumab pegol
The FINANCIAL -- UCB, a global biopharmaceutical company, announced the preliminary results of a recently completed Phase IIIb, multinational, randomized,...
Sanofi-aventis provides an R&D Pipeline update
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on December 21 an update of its R&D pipeline for four...
ADVERTISEMENT
Popular Last 24h
-
Zebra dies after ‘incident’with rhino at zoo
-
Government Contractor Agrees to Pay $1M to Resolve False Claims Act Allegations for Submitting Fraudulent Bids on Prime Vendor Contracts
-
Giant Pandas Will Make Their Public Debut Jan. 24 at Smithsonian’s National Zoo and Conservation Biology Institute
-
Gerald Durrell’s Centenary: a year of celebrations starts today
-
Minnesota Man Sentenced To 15 Months For Trafficking In Stolen Human Remains
-
ICE Acquires the American Financial Exchange (AFX)
-
How the Aging Brain Affects Thinking
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
